Product Information

EZETIMIBE-SIMVASTATIN 10-80 MG is a generic product labeled by NorthStar Rx LLC, priced at $0.2726 per EA under NDC 16714078102. Its NADAC has been published 352 times since Feb 5, 2020.

FDA first approved this application on Jun 27, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

EZETIMIBE-SIMVASTATIN 10-80 MG

ezetimibe and simvastatin
$0.2726per EA

Strength

10; 80 mg/1; mg/1

Manufacturer

NorthStar Rx LLC

NDC

16714078102

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

EZETIMIBE; SIMVASTATIN

Approval Type

Generic (ANDA)

FDA Application

ANDA208699

FDA Approved

6/27/2019

TE Code

AB

On Market Since

8/19/2019

Pharmacological Classes

Decreased Cholesterol Absorption
Dietary Cholesterol Absorption Inhibitor
HMG-CoA Reductase Inhibitor
Hydroxymethylglutaryl-CoA Reductase Inhibitors

Price Statistics

The NADAC for EZETIMIBE-SIMVASTATIN 10-80 MG has been published 352 times since Feb 5, 2020, and over the history we have for it it has declined 85.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2726 per EA
All-time high$2.0078 (Jul 15, 2020)
All-time low$0.2726 (Oct 21, 2026)
52-week high$0.4771
52-week low$0.2726
Median price$0.4962
Average price$0.7532
Largest weekly change-61.3% (Mar 23, 2022)
Weeks tracked352
Tracking sinceFeb 5, 2020

Price History

1W

N/A

1M

-4.3%

3M

-21.9%

6M

-39.1%

1Y

-34.5%

3Y

-44.8%

5Y

-80.2%

All

-85.0%

Last surveyed Oct 28, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 14% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of EZETIMIBE-SIMVASTATIN 10-80 MG?

The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE-SIMVASTATIN 10-80 MG, manufactured by NorthStar Rx LLC, is $0.2726 per EA (NDC 16714078102), effective Oct 28, 2026.

How has the price of EZETIMIBE-SIMVASTATIN 10-80 MG changed over time?

Over the history we have for it, the NADAC for EZETIMIBE-SIMVASTATIN 10-80 MG has declined 85.0%. It has been tracked across 352 weekly CMS publications since Feb 5, 2020.

What are the highest and lowest recorded NADAC prices for EZETIMIBE-SIMVASTATIN 10-80 MG?

Since Feb 5, 2020, the NADAC for EZETIMIBE-SIMVASTATIN 10-80 MG has ranged from a low of $0.2726 (Oct 21, 2026) to a high of $2.0078 (Jul 15, 2020), with a median of $0.4962 per EA.

Are there cheaper alternatives to EZETIMIBE-SIMVASTATIN 10-80 MG?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EZETIMIBE-SIMVASTATIN 10-80 MG, is $0.2357 per EA — about 14% below EZETIMIBE-SIMVASTATIN 10-80 MG.

Who manufactures EZETIMIBE-SIMVASTATIN 10-80 MG?

EZETIMIBE-SIMVASTATIN 10-80 MG (NDC 16714078102) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.